BioAdaptives, Inc. (BDPT) は上場企業です 生活必需品 セクターの Packaged Foods 業界で事業展開. 本社所在地は Las Vegas, NV, アメリカ. 現CEOは James E. Keener.
BDPT を有する IPO日 2014-07-09, 1 名の正社員, に上場 Other OTC, 時価総額 $109.44K.
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
